• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

PZ6:GR

6.538 EUR 0.203 3.01%

As of 03:00:29 ET on 04/24/2014.

Snapshot for Pozen Inc (PZ6)

Open: 6.538 Day's Range: 6.538 - 6.538 Volume: 0
Previous Close: 6.741 52wk Range: 2.773 - 6.761 1-Yr Rtn: +99.19%

Stock Chart for PZ6

No chart data available.
  • PZ6:GR 6.538
  • 1D
  • 1M
  • 1Y
6.741
Interactive PZ6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PZ6

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 33.4746
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.2700
Est. PEG Ratio -
Market Cap (M EUR) 201.50
Shares Outstanding (M) 30.82
30 Day Average Volume 262
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.7500
Dividend Ex-Date 12/31/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PZ6

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PZ6

POZEN Inc. is a pharmaceutical company that develops therapeutics for diseases with unmet medical needs. The Company's product candidates include migraine treatments as well as is exploring the development of product candidates in other pain-related therapeutic areas.

John R PlachetkaChairman/President/CEOJohn G FortChief Medical Officer
Tomas S BocanegraExec VP:Product DevelopmentDennis L McNamaraSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for PZ6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil